Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment?

Yakar F., Yakar A., Buyukpinarbasili N., Erelel M.

MEDICAL SCIENCE MONITOR, vol.22, pp.1218-1222, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22
  • Publication Date: 2016
  • Doi Number: 10.12659/msm.897638
  • Journal Name: MEDICAL SCIENCE MONITOR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1218-1222
  • Keywords: Antitubercular Agents, Carcinoma, Non-Small-Cell Lung, Tuberculosis, Pulmonary, RENAL-CELL CARCINOMA, LUNG-CANCER, PULMONARY TUBERCULOSIS, SARCOID REACTIONS, RISK, NEOPLASMS
  • Istanbul University Affiliated: Yes

Abstract

Background: Lung cancer and tuberculosis (TB) are two major public health problems. They can coexist or appear sequentially. In patients with TB, lung cancer risk is increased. However, vice versa is not crystal clear. In this study, we aimed to determine the development of TB in patients with resectabled non-small cell lung cancer (NSCLC) in a 2-year postoperative follow-up period.